#United States #Menlo Park #BillionToOne #Northstar Select #UNITY Complete

BillionToOne Strengthens Leadership for Enhanced Growth

BillionToOne, Inc., a prominent player in the molecular diagnostics industry, has recently expanded its executive team to accelerate the progress of its innovative platforms, UNITY and Northstar. The company, based in Menlo Park, California, is renowned for its commitment to delivering precise and accessible diagnostic tests designed for everyone.

Key Appointments

The firm has welcomed two distinguished leaders: Jean Hayden, who takes on the role of Vice President of Business Operations and Chief of Staff, and John Lister, who assumes the position of Chief Administrative Officer. These appointments are strategic moves aimed at bolstering BillionToOne's capabilities and reinforcing its commitment to growth as highlighted by Dr. Oguzhan Atay, co-founder and CEO of the company. Dr. Atay expressed his enthusiasm, stating, "We’re thrilled to welcome such talented leaders to BillionToOne. Both Jean and John bring a unique set of skills and experiences that will be instrumental as we scale our operations and become a generational company."

Jean Hayden's Extensive Experience

Jean Hayden arrives at BillionToOne with over two decades of experience in high-growth environments. Prior to her current role, she occupied significant positions such as COO and Head of Operations in various startups and established companies. Notably, during her tenure at Google Cloud, she served as Chief of Staff, supporting a remarkable revenue growth from $5 million to $1 billion in that division. At BillionToOne, Hayden will leverage her extensive background to oversee and refine business operations, aiming to sustain the company's rapid growth trajectory. Her insights will crucially assist BillionToOne in translating strategic goals into meaningful actions.

John Lister’s Impact on Organizational Growth

John Lister is set to lead as Chief Administrative Officer at BillionToOne, overseeing crucial departments like People, Legal, IT, and Quality Assurance/Regulatory Affairs. Lister has built an impressive career, notably at Dexcom, where he was pivotal in the company’s phenomenal expansion, growing staff from just 70 to over 6,000 and increasing revenue to over $1.5 billion. He has also previously worked as COO for Tidepool and brings with him a wealth of experience that will undoubtedly enhance BillionToOne's operational strategy and management.

Innovations in Diagnostics

BillionToOne is well-regarded for its cutting-edge UNITY Complete® service, a non-invasive prenatal testing solution that assesses fetal risks for various genetic conditions. It uniquely utilizes a single maternal blood sample to deliver results about recessive and X-linked genes, enhancing prenatal care through early detection and personalized healthcare strategies. In parallel, the firm offers Northstar Select® and Northstar Response®, advanced liquid biopsy tests transforming oncology with unparalleled sensitivity and precision. These innovations have positioned BillionToOne at the forefront of both prenatal and cancer diagnostic fields, as it continues refining its offerings to provide clinicians with essential insights for making informed decisions.

Looking Ahead

As BillionToOne forges ahead with its ambitious agenda, the newly appointed executives are expected to play a critical role in steering the company towards new heights within the molecular diagnostics space. With their extensive backgrounds in scaling organizations and optimizing operational efficiency, BillionToOne is poised for significant advancements in shaping patient outcomes through revolutionary diagnostic solutions.

To discover more about BillionToOne and their innovative diagnostic platforms, visit their official website at www.billiontoone.com.